Engineering of cell membranes with a bisphosphonate-containing polymer using ATRP synthesis for bone targeting

Biomaterials

Volumn 35, Issue 35, 2014, Pages 9447-9458

  D'Souza, Sonia ^a   Murata, Hironobu ^a   Jose, Moncy V ^b,c   Askarova, Sholpan ^d   Yantsen, Yuliya ^d   Andersen, Jill D ^a   Edington, Collin D J ^a   Clafshenkel, William P ^a   Koepsel, Richard R ^a   Russell, Alan J ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c PolyOne Technology and Innovation Center   (United States)

^d NAZARBAYEV UNIVERSITY   (Kazakhstan)

Author keywords

ATRP; Bone targeting polymer; Cell reactive polymers; Membrane engineering

Indexed keywords

ATOM TRANSFER RADICAL POLYMERIZATION; BONE; CALCIUM ION SENSORS; CELL CULTURE; FREE RADICAL REACTIONS; HYDROXYAPATITE; STEM CELLS;

ADHESION PROPERTIES; BONE TARGETING; COVALENT COUPLINGS; HYDROXYAPATITE CRYSTALS; MEMBRANE ENGINEERINGS; MESENCHYMAL STEM CELL; N-HYDROXYSUCCINIMIDE; WATERSOLUBLE POLYMERS;

CELL ENGINEERING;

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; POLYMER; N-HYDROXYSUCCINIMIDE; SUCCINIMIDE DERIVATIVE;

ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; BONE; CELL ADHESION; CELL ENGINEERING; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; COVALENT BOND; HL 60 CELL LINE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PH; PHYSIOLOGY; POLYMERIZATION; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; DIPHOSPHONATES; HL-60 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MESENCHYMAL STROMAL CELLS; POLYMERIZATION; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINIMIDES; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 84961288380     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.041     Document Type: Article

References (41)

1. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. JCell Biol 2010, 188:759-768.
2. Kopecek J., Kopeckova P. HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 2010, 62:122-149.
3. Zhang S., Gangal G., Uludag H. 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev 2007, 36:507-531.
4. Wang D., Miller S.C., Kopeckova P., Kopecek J. Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev 2005, 57:1049-1076.
5. Sato M., Grasser W., Endo N., Akins R., Simmons H., Thompson D.D., et al. Bisphosphonate action. alendronate localization in rat bone and effects on osteoclast ultrastructure. JClin Invest 1991, 88:2095-2105.
6. Russell R.G., Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999, 25:97-106.
7. Woo S.B., Hellstein J.W., Kalmar J.R. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006, 144:753-761.
8. Zhang S., Wright J.E., Ozber N., Uludag H. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite. Macromol Biosci 2007, 7:656-670.
9. Wang D., Miller S., Sima M., Kopeckova P., Kopecek J. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems. Bioconjug Chem 2003, 14:853-859.
10. Segal E., Pan H., Ofek P., Udagawa T., Kopeckova P., Kopecek J., et al. Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics. PLoS One 2009, 4. e5233.
11. Caplan A.I. Mesenchymal stem cells. JOrthop Res 1991, 9:641-650.
12. Colter D.C., Class R., DiGirolamo C.M., Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000, 97:3213-3218.
13. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
14. Fouillard L., Chapel A., Bories D., Bouchet S., Costa J.M., Rouard H., et al. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 2007, 21:568-570.
15. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004, 94:92-95.
16. Lee P.H., Kim J.W., Bang O.Y., Ahn Y.H., Joo I.S., Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 2008, 83:723-730.
17. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
18. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57:874-882.
19. Kraitchman D.L., Tatsumi M., Gilson W.D., Ishimori T., Kedziorek D., Walczak P., et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005, 112:1451-1461.
20. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25:2896-2902.
21. Hasegawa T., Miwa M., Sakai Y., Niikura T., Lee S.Y., Oe K., et al. Efficient cell-seeding into scaffolds improves bone formation. JDent Res 2010, 89:854-859.
22. Panza J.L., Wagner W.R., Rilo H.L., Rao R.H., Beckman E.J., Russell A.J. Treatment of rat pancreatic islets with reactive PEG. Biomaterials 2000, 21:1155-1164.
23. Deible C.R., Petrosko P., Johnson P.C., Beckman E.J., Russell A.J., Wagner W.R. Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol. Biomaterials 1998, 19:1885-1893.
24. Burchenal J.E., Deible C.R., Deglau T.E., Russell A.J., Beckman E.J., Wagner W.R. Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries. JThromb Thrombolysis 2002, 13:27-33.
25. Helfer B.M., Balducci A., Nelson A.D., Janjic J.M., Gil R.R., Kalinski P., et al. Functional assessment of human dendritic cells labeled for invivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 2010, 12:238-250.
26. Guan M., Yao W., Liu R., Lam K.S., Nolta J., Jia J., et al. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 2012, 18:456-462.
27. Murata H., Pruker O., Ruhe J. Synthesis of functionalized polymer monolayers from active ester brushes. Macromolecules 2007, 40:5497-5503.
28. Ciampolini M., Nardi N. Five-coordinated high-spin complexes of bivalent cobalt, nickel, and copper with tris(2-dimethylaminoethyl)amine. Inorg Chem 1966, 5:41-44.
29. Matyjaszewski K., Xia J. Atom transfer radical polymerization. Chem Rev 2001, 101:2921-2990.
30. Leu C.T., Luegmayr E., Freedman L.P., Rodan G.A., Reszka A.A. Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy. Bone 2006, 38:628-636.
31. Xu H., Kaar J.L., Russell A.J., Wagner W.R. Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion. Biomaterials 2006, 27:3125-3135.
32. Erzurum S.C., Kus M.L., Bohse C., Elson E.L., Worthen G.S. Mechanical properties of HL60 cells: role of stimulation and differentiation in retention in capillary-sized pores. Am J Respir Cell Mol Biol 1991, 5:230-241.
33. Miki K., Oride K., Kimura A., Kuramochi Y., Matsuoka H., Harada H., et al. Influence of side chain length on fluorescence intensity of ROMP-based polymeric nanoparticles and their tumor specificity in in-vivo tumor imaging. Small 2011, 7:3536-3547.
34. Gaylord B.S., Wang S., Heeger A.J., Bazan G.C. Water-soluble conjugated oligomers: effect of chain length and aggregation on photoluminescence-quenching efficiencies. JAm Chem Soc 2001, 123:6417-6418.
35. Baumann H., Doyle D. Turnover of plasma membrane glycoproteins and glycolipids of hepatoma tissue culture cells. JBiol Chem 1978, 253:4408-4418.
36. Doetschman T.C. Cell surface turnover and shedding of fucosyl-glycoprotein in L6 cells. Cell Biol Int Rep 1980, 4:379-390.
37. Chu F.F., Doyle D. Turnover of plasma membrane proteins in rat hepatoma cells and primary cultures of rat hepatocytes. JBiol Chem 1985, 260:3097-3107.
38. Hubbard A.L., Cohn Z.A. Externally disposed plasma membrane proteins. II. Metabolic fate of iodinated polypeptides of mouse L cells. JCell Biol 1975, 64:461-479.
39. Tweto J., Doyle D. Turnover of the plasma membrane proteins of hepatoma tissue culture cells. JBiol Chem 1976, 251:872-882.
40. Gil L., Han Y., Opas E.E., Rodan G.A., Ruel R., Seedor J.G., et al. Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis. Bioorg Med Chem 1999, 7:901-919.
41. Uludag H., Yang J. Targeting systemically administered proteins to bone by bisphosphonate conjugation. Biotechnol Prog 2002, 18:604-611.